Pediatric and Adult High-Grade Glioma Stem Cell Culture Models Are Permissive to Lytic Infection with Parvovirus H-1

Transforming growth factor β and bone morphogenetic protein actions in brain tumors

(2015) Laia Caja et al.   FEBS LETTERS

Unravelling tumour heterogeneity—implications for therapy

(2015) David A. Reardon et al.   Nature Reviews Clinical Oncology

Hepatitis B virus hijacks CTHRC1 to evade host immunity and maintain replication

(2015) Lan Bai et al.   Journal of Molecular Cell Biology

Human pontine glioma cells can induce murine tumors

(2014) Viola Caretti et al.   ACTA NEUROPATHOLOGICA

Connect Four with Glioblastoma Stem Cell Factors

(2014) Jan Gronych et al.   CELL

Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1

(2014) J Bageritz et al.   CELL DEATH AND DIFFERENTIATION

γ134.5-deleted HSV-1-expressing human cytomegalovirus IRS1 gene kills human glioblastoma cells as efficiently as wild-type HSV-1 in normoxia or hypoxia

(2014) G K Friedman et al.   GENE THERAPY

Neurotrophin Signaling via TrkB and TrkC Receptors Promotes the Growth of Brain Tumor-initiating Cells

(2014) Samuel Lawn et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma

(2014) Kathryn R Taylor et al.   NATURE GENETICS

Glioma virus therapies between bench and bedside

(2014) J. K. Kaufmann et al.   NEURO-ONCOLOGY

TRIM38 inhibits TNF - and IL-1 -triggered NF- B activation by mediating lysosome-dependent degradation of TAB2/3

(2014) M.-M. Hu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

(2014) A. P. Patel et al.   SCIENCE

Oncolytic Virotherapy as Emerging Immunotherapeutic Modality: Potential of Parvovirus H-1

(2014) Markus Moehler et al.   Frontiers in Oncology

Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays

(2013) Volker Hovestadt et al.   ACTA NEUROPATHOLOGICA

The role of IFITM3 in the growth and migration of human glioma cells

(2013) Bing Zhao et al.   BMC Neurology

Specific Elimination of CD133+ Tumor Cells with Targeted Oncolytic Measles Virus

(2013) P. Bach et al.   CANCER RESEARCH

Clinical trials of viral therapy for malignant gliomas

(2013) David E Piccioni et al.   Expert Review of Anticancer Therapy

Unclear standard of care for pediatric high grade glioma patients

(2013) Jason Fangusaro et al.   JOURNAL OF NEURO-ONCOLOGY

Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma

(2013) B. E. Johnson et al.   SCIENCE

Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN

(2013) Lynn Bjerke et al.   Cancer Discovery

Innate immune responses to DNA viruses

(2013) Ying Nie et al.   Protein & Cell

Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol

(2012) Karsten Geletneky et al.   BMC CANCER

Molecular Pathways: Rodent Parvoviruses--Mechanisms of Oncolysis and Prospects for Clinical Cancer Treatment

(2012) J. P. F. Nuesch et al.   CLINICAL CANCER RESEARCH

High-throughput SNP-based authentication of human cell lines

(2012) Felipe Castro et al.   INTERNATIONAL JOURNAL OF CANCER

Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas

(2012) Gordon Li et al.   JOURNAL OF NEURO-ONCOLOGY

The GM2 Glycan Serves as a Functional Coreceptor for Serotype 1 Reovirus

(2012) Kerstin Reiss et al.   PLoS Pathogens

The Value of Glioma Extent of Resection in the Modern Neurosurgical Era

(2012) Douglas A. Hardesty et al.   Frontiers in Neurology

Pediatric High Grade Glioma: a Review and Update on Tumor Clinical Characteristics and Biology

(2012) Jason Fangusaro   Frontiers in Oncology

Diffuse intrinsic pontine glioma: poised for progress

(2012) Katherine E. Warren   Frontiers in Oncology

Enhanced Antitumor Efficacy of Low-Dose Etoposide with Oncolytic Herpes Simplex Virus in Human Glioblastoma Stem Cell Xenografts

(2011) T. A. Cheema et al.   CLINICAL CANCER RESEARCH

Regression of Glioma in Rat Models by Intranasal Application of Parvovirus H-1

(2011) Irina Kiprianova et al.   CLINICAL CANCER RESEARCH

TRIM5 is an innate immune sensor for the retrovirus capsid lattice

(2011) Thomas Pertel et al.   NATURE

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells

(2011) H. Wakimoto et al.   NEURO-ONCOLOGY

Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells

(2010) B. Campos et al.   CLINICAL CANCER RESEARCH

Structure-Function Analyses Point to a Polynucleotide-Accommodating Groove Essential for APOBEC3A Restriction Activities

(2010) Y. Bulliard et al.   JOURNAL OF VIROLOGY

Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models

(2010) K. Geletneky et al.   NEURO-ONCOLOGY

Human Glioblastoma-Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors

(2009) H. Wakimoto et al.   CANCER RESEARCH

Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111

(2009) Gregory K. Friedman et al.   JOURNAL OF NEURO-ONCOLOGY

High-throughput detection and multiplex identification of cell contaminations

(2009) M. Schmitt et al.   NUCLEIC ACIDS RESEARCH

Deaminase-Independent Inhibition of Parvoviruses by the APOBEC3A Cytidine Deaminase

(2009) Iñigo Narvaiza et al.   PLoS Pathogens